Contact us
Search
About Us
Board Members
Our Leadership
Partners
Scientific Approach
Pipeline
VTX-801 - Wilson disease
> GATEWAY - Phase 1/2 Clinical Trial of VTX-801 in Wilson disease
VTX-802 & VTX-803 - PFIC
VTX-804 - Citrullinemia Type 1
Investors
Work at Vivet
News & Events
News
Events
Research & Publications
Patients & Families
Patient Advocacy
Patients & Families Resources
Compassionate Use and Expanded Access
Vivet Therapeutics will be at
AASLD Liver Meeting 2017
in Washington on October 20-24th.
BACK
ENGLISH
ESPAÑOL